NCT07360314
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07360314
Title Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors EMD Serono Research & Development Institute, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | CAN

Facility Status City State Zip Country Details
Yale University - Yale University School of Medicine NOT_YET_RECRUITING New Haven Connecticut 06510 United States Details
Carolina BioOncology Institute, LLC - Cancer Therapy and Research Center NOT_YET_RECRUITING Huntersville North Carolina 28078 United States Details
NEXT Houston NOT_YET_RECRUITING Galveston Texas 77001 United States Details
NEXT Oncology - PARENT NOT_YET_RECRUITING San Antonio Texas 78229 United States Details
Princess Margaret Cancer Centre NOT_YET_RECRUITING Toronto Canada Details
BC Cancer - Vancouver - BC Cancer Agency NOT_YET_RECRUITING Vancouver Canada Details
National Cancer Center Hospital RECRUITING Tokyo Japan Details
NEXT Madrid - Hospital Universitario Quironsalud Madrid NOT_YET_RECRUITING Madrid Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field